Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Zhongyu Yuan"'
Autor:
Huiping Li, Yongmei Yin, Xiao Jia Wang, Zhongyu Yuan, Cuizhi Geng, Pin Zhang, Xichun Hu, Yongsheng Wang, Jing Cheng, Binghe Xu, Rou-Jun Peng, Zefei Jiang, Qingyuan Zhang, Jian Liu, Baochun Zhang, Zhongsheng Tong, Shude Cui, Shaohua Zhang, Hongming Pan, Hong Zheng, Li Tang, Tao Sun, Yuee Teng, Qiang Yao, Jian Huang, Min Yan, Jinsong Lu, Rongguo Qiu, Junlan Yang, Ping Sun
Publikováno v:
The Lancet Oncology. 18:371-383
Utidelone, a genetically engineered epothilone analogue, has shown promise as a potential treatment for breast cancer in phase 1 and 2 trials. The aim of this phase 3 trial was to compare the efficacy and safety of utidelone plus capecitabine versus
Autor:
Kaping Lee, Yan Xia Shi, Wen Xia, Qiufan Zheng, S. Wang, Fei Xu, Zhongyu Yuan, Y. Zeng, M.T. Kong, Ge Qin, Ruoxi Hong, Qianyi Lu, Tao Qin, Kai Zhang
Publikováno v:
Annals of Oncology. 28:v29-v30
Autor:
Huijuan Qiu, Feifei Zhou, Chenxi Yin, Liangping Xia, Guifang Guo, Fang Wang, Xuxian Chen, Yuming Rong, Zhongyu Yuan, Xi Wang, Wenzhuo He
Publikováno v:
Clinical Breast Cancer. 12:404-411
Background The lymph node ratio (LNR) classification has shown superiority to pN staging (the number of positive lymph nodes) in breast cancers, but it has not been examined according to whether sufficient lymph nodes have been dissected. Methods All